Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Directorate Change

10 Mar 2023 09:00

RNS Number : 4972S
Phoenix Group Holdings PLC
10 March 2023
 

LEI: 2138001P49OLAEU33T68

 

9 March 2023

 

Phoenix Group Holdings plc - Board Changes

 

The Board of Phoenix Group Holdings plc ("Phoenix Group" or "the Group") announces that Kory Sorenson will retire from the Board on 30 June 2023 after serving 9 years as an Independent Non-Executive Director. Kory has served as Chair of the Remuneration Committee since 11 May 2017 and as a member of the Nomination, Risk and Sustainability Committees.

 

Kory will be succeeded as Chair of the Remuneration Committee by Nicholas Shott with effect from the conclusion of the Annual General Meeting on 4 May 2023, subject to shareholder and regulatory approvals.

 

This announcement is made pursuant to LR 9.6.11 of the Listing Rules.

 

The Phoenix Board is pleased to announce that Mark Gregory will be appointed as an independent Non-Executive Director and a member of the Risk Committee with effect from 1 April 2023.

 

Mark is a former FTSE 100 Chief Financial Officer and divisional Chief Executive Officer ("CEO") with a breadth of experience across financial services and retail. He has a deep knowledge and understanding of the Insurance industry gained from a near 20 year career at Legal & General (L&G), as well as non-executive roles on FTSE 100 and 250 Boards.

 

He has extensive experience in both life and general insurance, audit, regulation, investment management and M&A with recent executive experience at L&G and Merian Global Investors. Mark is currently a Non-Executive Director at Direct Line Insurance Group plc where he is also their Chair of the Risk Committee and a Member of the Audit, Remuneration and Investment Committees.

 

Mark was a Non-Executive Director, Chair of the Remuneration Committee and a Member of the Audit and Nomination Committees at Entain plc.  Mark was also CEO of Merian Global Investors from January 2019 to August 2020.

 

Commenting on the changes, Alastair Barbour, Chair of Phoenix Group said:

"I would like to thank Kory for the significant contribution she has made to Phoenix during her time on the Board, in particular as Chair of the Remuneration Committee for almost 6 years."

 

"We are delighted that Mark has agreed to join the Board of Phoenix Group Holdings plc. He is an accomplished executive with significant experience in the financial services, insurance and investment management sectors and will bring additional capability/skills as Phoenix pursues its long-term strategy". 

 

There is no further information required to be notified under Listing Rule 9.6.13 R with regard to Mark's appointment referred to above.

 

Enquiries:

Media Douglas Campbell

Teneo

+44 (0)7753 136628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0) 204 559 3031

Investors Claire Hawkins, Corporate Affairs Director, Phoenix Group +44 (0) 204 559 3161

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0) 204 559 3145

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGZGGFNLFGFZM
Date   Source Headline
3rd Jul 20233:30 pmRNSTotal Voting Rights
30th Jun 202311:30 amRNSPublication of a Prospectus
16th Jun 20233:01 pmRNSDirector Declaration
12th Jun 20231:30 pmRNSBlock Listing Return
7th Jun 20238:38 amRNSDirector/PDMR Shareholding
1st Jun 20231:24 pmRNSBlock Listing Application
1st Jun 20231:00 pmRNSTotal Voting Rights
16th May 202312:10 pmRNSDirector/PDMR Shareholding
11th May 20236:00 pmRNSDirectorate Change
10th May 20234:06 pmRNSDirector/PDMR Shareholding
4th May 20233:35 pmRNSHolding(s) in Company
4th May 20232:19 pmRNSResult of AGM
2nd May 20233:00 pmRNSTotal Voting Rights
6th Apr 20233:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSTotal Voting Rights
3rd Apr 20238:02 amRNSAcquisition
30th Mar 20232:00 pmRNSDirector/PDMR Shareholding
28th Mar 20234:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20233:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20235:45 pmRNSNotice of AGM
22nd Mar 20233:00 pmRNSDirector/PDMR Shareholding
20th Mar 20235:00 pmRNSDirector/PDMR Shareholding
15th Mar 20235:30 pmRNSDirector/PDMR Shareholding
13th Mar 20233:00 pmRNSDirector/PDMR Shareholding
13th Mar 20237:00 amRNS2022 Annual Financial Report
10th Mar 20239:31 amRNSDirectorate Change - Replacement
10th Mar 20239:00 amRNSDirectorate Change
8th Mar 20234:00 pmRNSDirector/PDMR Shareholding
1st Mar 20232:00 pmRNSTotal Voting Rights
7th Feb 20233:45 pmRNSMiscellaneous - PGH/TCS Extension of Partnership
7th Feb 20232:30 pmRNSDirector/PDMR Shareholding
1st Feb 20232:00 pmRNSTotal Voting Rights
6th Jan 20234:30 pmRNSDirector/PDMR Shareholding
30th Dec 20221:00 pmRNSTotal Voting Rights
12th Dec 20224:30 pmRNSBlock listing Interim Review
7th Dec 20224:45 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSTrading Statement
30th Nov 20222:00 pmRNSTotal Voting Rights
8th Nov 20225:30 pmRNSDirector/PDMR Shareholding
31st Oct 20226:00 pmRNSTotal Voting Rights
12th Oct 20224:00 pmRNSDirectorate Change
6th Oct 20224:30 pmRNSDirector/PDMR Shareholding
6th Oct 20224:30 pmRNSDirector/PDMR Shareholding
4th Oct 20224:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20224:30 pmRNSTotal Voting Rights
14th Sep 20224:30 pmRNSDirector/PDMR Shareholding
9th Sep 202211:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.